Prognostic features for response and survival in elderly patients with <emph type="3">de novo</emph> acute myeloid leukemia treated with mitoxantrone and intermediate dose cytarabine

AP Grigg, J Reynolds, A McQuillan, SK Juneja, J Di Iulio, C Hui, C Smith, R Kimber, KF Bradstock, on behalf of the Australasian Leukaemia and Lymphoma Group

Research output: Contribution to journalArticleResearchpeer-review

7 Citations (Scopus)
Original languageEnglish
Pages (from-to)367-375
Number of pages9
JournalLeukemia and Lymphoma
Volume46
Issue number3
DOIs
Publication statusPublished - 1 Jan 2005

Cite this